Myriad Genetics Historical PE Ratio image   This MYGN PE ratio history page last updated 3/11/2024
Myriad Genetics Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
2/27/2024
23.500.040.16146.9
Q3 2023
11/6/2023
16.34-0.03-0.12NA
Q2 2023
8/3/2023
20.76-0.08-0.32NA
Q1 2023
5/3/2023
21.89-0.21-0.84NA
Q4 2022
2/28/2023
18.92-0.12-0.48NA
Q2 2022
8/4/2022
27.400.040.16171.2
Q1 2022
5/5/2022
21.62-0.03-0.12NA
Q4 2021
2/24/2022
25.47-0.02-0.08NA
Q3 2021
11/2/2021
30.80-0.02-0.08NA
Q2 2021
8/3/2021
35.230.120.4873.4
Q1 2021
5/3/2021
30.40-0.06-0.24NA
Q2 2021
2/23/2021
29.03-0.12-0.48NA
Q1 2021
11/9/2020
17.00-0.15-0.60NA
Q4 2020
8/13/2020
13.38-0.31-1.24NA
Q3 2020
5/5/2020
14.82-0.08-0.32NA
Q2 2020
2/6/2020
29.290.230.9231.8
Q1 2020
11/4/2019
35.100.080.32109.7
Q4 2019
8/13/2019
44.550.411.6427.2
Q3 2019
5/7/2019
34.330.461.8418.7
Q2 2019
2/5/2019
27.870.381.5218.3
Q1 2019
11/6/2018
36.670.431.7221.3
Q4 2018
8/21/2018
42.840.381.5228.2
Q3 2018
5/8/2018
33.550.311.2427.1
Q2 2018
2/6/2018
35.810.311.2428.9
Q1 2018
11/7/2017
29.900.261.0428.7
Q4 2017
8/8/2017
25.550.301.2021.3
Q3 2017
5/2/2017
18.680.271.0817.3
Q2 2017
2/7/2017
15.400.261.0414.8
Q1 2017
11/1/2016
19.490.230.9221.2
Q4 2016
8/9/2016
29.460.361.4420.5
Q3 2016
5/3/2016
36.190.411.6422.1
Q2 2016
2/2/2016
38.430.451.8021.3
Q1 2016
11/3/2015
42.320.411.6425.8
Q4 2015
8/11/2015
31.080.411.6419.0
Q3 2015
5/5/2015
34.540.401.6021.6
Q2 2015
2/3/2015
38.120.401.6023.8
Q1 2015
11/4/2014
36.890.251.0036.9
Q4 2014
8/12/2014
39.000.481.9220.3
Q3 2014
5/6/2014
40.880.481.9221.3
Q2 2014
2/4/2014
27.180.662.6410.3
Q1 2014
11/5/2013
25.180.682.729.3
Q4 2013
8/13/2013
30.250.532.1214.3
Q3 2013
5/7/2013
28.300.461.8415.4
Q2 2013
2/5/2013
27.140.421.6816.2
Q1 2013
11/5/2012
26.850.361.4418.6
Q4 2012
8/14/2012
25.470.341.3618.7
Q3 2012
5/1/2012
25.970.341.3619.1
Q2 2012
1/31/2012
23.660.331.3217.9
Q1 2012
11/1/2011
20.330.291.1617.5
Myriad Genetics PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
2/27/2024
23.500.04-0.28NA
Q3 2023
11/6/2023
16.34-0.03-0.44NA
Q2 2023
8/3/2023
20.76-0.08-0.41NA
Q1 2023
5/3/2023
21.89-0.21-0.29NA
Q4 2022
2/28/2023
18.92-0.12-0.11NA
Q2 2022
8/4/2022
27.400.04-0.03NA
Q1 2022
5/5/2022
21.62-0.030.05432.4
Q4 2021
2/24/2022
25.47-0.020.02>500
Q3 2021
11/2/2021
30.80-0.02-0.08NA
Q2 2021
8/3/2021
35.230.12-0.21NA
Q1 2021
5/3/2021
30.40-0.06-0.64NA
Q2 2021
2/23/2021
29.03-0.12-0.66NA
Q1 2021
11/9/2020
17.00-0.15-0.31NA
Q4 2020
8/13/2020
13.38-0.31-0.08NA
Q3 2020
5/5/2020
14.82-0.080.6423.2
Q2 2020
2/6/2020
29.290.231.1824.8
Q1 2020
11/4/2019
35.100.081.3326.4
Q4 2019
8/13/2019
44.550.411.6826.5
Q3 2019
5/7/2019
34.330.461.6520.8
Q2 2019
2/5/2019
27.870.381.5018.6
Q1 2019
11/6/2018
36.670.431.4325.6
Q4 2018
8/21/2018
42.840.381.2634.0
Q3 2018
5/8/2018
33.550.311.1828.4
Q2 2018
2/6/2018
35.810.311.1431.4
Q1 2018
11/7/2017
29.900.261.0927.4
Q4 2017
8/8/2017
25.550.301.0624.1
Q3 2017
5/2/2017
18.680.271.1216.7
Q2 2017
2/7/2017
15.400.261.2612.2
Q1 2017
11/1/2016
19.490.231.4513.4
Q4 2016
8/9/2016
29.460.361.6318.1
Q3 2016
5/3/2016
36.190.411.6821.5
Q2 2016
2/2/2016
38.430.451.6723.0
Q1 2016
11/3/2015
42.320.411.6226.1
Q4 2015
8/11/2015
31.080.411.4621.3
Q3 2015
5/5/2015
34.540.401.5322.6
Q2 2015
2/3/2015
38.120.401.6123.7
Q1 2015
11/4/2014
36.890.251.8719.7
Q4 2014
8/12/2014
39.000.482.3017.0
Q3 2014
5/6/2014
40.880.482.3517.4
Q2 2014
2/4/2014
27.180.662.3311.7
Q1 2014
11/5/2013
25.180.682.0912.0
Q4 2013
8/13/2013
30.250.531.7717.1
Q3 2013
5/7/2013
28.300.461.5817.9
Q2 2013
2/5/2013
27.140.421.4618.6
Q1 2013
11/5/2012
26.850.361.3719.6
Q4 2012
8/14/2012
25.470.341.3019.6
Q3 2012
5/1/2012
25.970.34NANA
Q2 2012
1/31/2012
23.660.33NANA
Q1 2012
11/1/2011
20.330.29NANA
Quotes delayed 20 minutes

Email EnvelopeFree MYGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Myriad Genetics (MYGN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

MYMD PE Ratio History
NAOV PE Ratio History
NARI PE Ratio History
NATR PE Ratio History
NBIX PE Ratio History
NBSE PE Ratio History
NDRA PE Ratio History
NEO PE Ratio History
NEOG PE Ratio History
NERV PE Ratio History
How should the MYGN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Myriad Genetics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this MYGN Historical PE Ratio page.

What is the average historical PE for MYGN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The MYGN historical PE ratio using the annualized quarterly earnings method works out to 32.3.

What is the average historical PE for MYGN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The MYGN historical PE ratio using the TTM earnings method works out to 33.7.

On this page we presented the Myriad Genetics Historical PE Ratio information for Myriad Genetics' stock. The average MYGN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 32.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MYGN historical PE based on this TTM earnings result method is 33.7. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MYGN historical PE result, against the recent PE: when this page was posted on 3/8/2024, the most recent closing price for MYGN had been 22.61, and the most recent quarterly earnings result, annualized, was 0.16. Meanwhile, the most recent TTM earnings summed to 0.05. From these numbers, we calculate the recent MYGN PE on 3/8/2024 based on annualized quarterly EPS was 141.3. Based on MYGN's history, that recent PE is elevated relative to the historical average, with the recent PE 337.5% higher than the historical average PE across our data set for Myriad Genetics. Looking at the recent MYGN PE on 3/8/2024 based on TTM EPS, we calculate the ratio at 452.2. Based on MYGN's history, that recent PE is elevated relative to the historical average, with the recent PE 1241.8% higher than the historical average PE across our Myriad Genetics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on MYGN or any other given stock, valuation analysis for MYGN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Myriad Genetics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MYGN. Thanks for visiting, and the next time you need to research MYGN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: REPL Videos, Funds Holding ERX, Information Technology Services IPOs.

 

Myriad Genetics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.